Three-arm randomised controlled phase 2 study comparing pemetrexed and erlotinib to either pemetrexed or erlotinib alone as second-line treatment for never-smokers with non-squamous non-small cell lung cancer
Ki Hyeong Lee(Asan Medical Center), Jung Shin Lee(Asan Medical Center), Sang‐We Kim(Asan Medical Center), José Rodrigues-Pereira(Brazilian Medical Association), Baohui Han(Shanghai Chest Hospital), Xiangqun Song(Guangxi Medical University), Jie Wang(Beijing Chest Hospital), Hoon-Kyo Kim(The Catholic University of Korea St. Vincent's Hospital), Tarini Prasad Sahoo(Chirayu Medical College & Hospital), Raghunadharao Digumarti(Nizam's Institute of Medical Sciences), Xin Wang(Lilly (China)), Sedat Altuǧ(Eli Lilly (United States)), Mauro Orlando
Cited by 78
Abstract
Related Papers
No related papers found
Powered by citation graph analysis